Bottom line
FBT vs IBBQ: the short answer
FBT (First Trust NYSE Arca Biotechnology Index Fund) and IBBQ (Invesco Nasdaq Biotechnology ETF) are quite different portfolios: only about 25% of their top holdings (by weight) are shared.
But IBBQ is far broader, holding 261 positions to 32 for FBT, so beyond the top names it adds exposure FBT doesn't have.
IBBQ is cheaper at 0.19% vs 0.55% — a difference of $36 a year per $10,000 invested.
Over one year, FBT returned +24.1% vs −0.6% for IBBQ (reporting dates differ).
Updated Nov 19, 2026
FBT vs IBBQ side by side
| FBT | IBBQ | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | First Trust | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.55% | 0.19% |
| Annual cost per $10k | $55 | $19 |
| 10-yr cost on $10k (prospectus) | — | $242 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +24.1% | −0.6% |
| 5-yr return (annualized) | +4.3% | — |
| 10-yr return (annualized) | +6.3% | — |
| Best quarter | +27.8% | +12.0% |
| Worst quarter | −22.5% | −11.7% |
| Net assets (fund) | $2.8B | $67.4M |
| Number of holdings | 32 | 261 |
| Portfolio turnover | 37% | 17% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FBT | IBBQ | Difference |
|---|---|---|---|
| 2024 | +5.8% | −0.6% | +6.4% |
| 2023 | +2.3% | +4.5% | −2.2% |
| 2022 | −4.6% | −10.2% | +5.6% |
Source: Fund prospectus bar charts
Holdings overlap
10 of FBT's top 25 holdings also appear in IBBQ's top 25.
| Holding | FBT | IBBQ |
|---|---|---|
| Illumina Inc | 3.92% | 1.98% |
| Neurocrine Biosciences Inc | 3.53% | 1.26% |
| Biogen Inc | 3.37% | 2.29% |
| Exelixis Inc | 3.32% | 1.04% |
| Incyte Corp | 3.18% | 1.53% |
| Argenx Se | 3.13% | 1.89% |
| Vertex Pharmaceuticals Inc | 3.07% | 7.38% |
| Amgen Inc | 2.78% | 7.10% |
| United Therapeutics Corp | 2.56% | 1.94% |
| Alnylam Pharmaceuticals Inc | 2.52% | 3.19% |
Source: SEC Form N-PORT
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between FBT and IBBQ?
Which is cheaper, FBT or IBBQ?
Should I own both FBT and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.